Understanding New Recommendations for Respiratory Syncytial Virus Prevention in Pregnancy
- Brenna Hughes; Rebecca Horgan; Jerri Waller; Yara Hage Diab; George Saade
Access Resources
About
This article explains new guidelines for preventing respiratory syncytial virus (RSV) in pregnant women. RSV is a major cause of illness in infants. Previously, prevention focused on giving antibodies to high-risk newborns and encouraging breastfeeding. Now, health experts recommend all newborns receive antibodies during RSV season. A new vaccine for pregnant women has been approved to protect babies from RSV if they are not planning other antibody treatments like nirsevimab for their infants. The article reviews the evidence and future considerations for using this vaccine during pregnancy to help keep babies safe from RSV-related illnesses.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.